Health technology company.
Translational Scientist II, Translational Research
Passionate about precision medicine and advancing the healthcare industry?
Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
Translational Scientist II, Translational Research
With the advent of genomic sequencing, we can finally decode and process our genetic makeup; however, computer technology has had a limited impact in healthcare. With the expansion of multi-modal healthcare data and recent advancements in AI, that’s about to fundamentally change. Tempus is a healthcare technology company at the forefront of that change by leveraging data to improve patient lives.
Tempus' proprietary data and platform connect an entire ecosystem of real-world data to deliver real-time, actionable insights to physicians. Our data empowers researchers to better characterize and understand disease, and to drive better outcomes through precise, individualized care.
The Translational Scientist II, Translational Research will execute research projects for early stage biopharmaceutical partners. This role involves performing complex computational analyses, and providing interpreted insights to guide decision-making for biopharma clients. The ideal candidate will possess strong genomic analytical skills and the ability to communicate complex scientific findings to various stakeholders.
Key Responsibilities:
-
Independent Contribution: Independently execute complex translational research projects integrating molecular and clinical data from Tempus multimodal data platform to derive real-world insights for biopharma partners
-
Scientific Communication: Present scientific findings clearly and meaningfully to diverse sets of external stakeholders
-
Continuous Improvement: Stay current with industry trends, best practices, and advancements in computational oncology research. Apply this knowledge to enhance research methodologies and improve overall research quality on team
Qualifications:
-
Education: PhD degree in a quantitative discipline (e.g. Biostatistics/Statistical Genetics, Cancer Genetics, Bioinformatics, Computational Biology, Computational Immunology or similar) or, a PhD in Molecular Biology or Immunology combined with a very strong record of computational biology. Alternatively an MSc degree with 4+ years of industry experience.
-
Technical/Scientific Skills: Highly proficient in R (ideally Rmd and/or RShiny)
-
Communication Skills: Excellent written and verbal communication skills, with the ability to present complex information clearly and persuasively to diverse audiences.
Preferred Skillsets/Background:
-
Strong understanding of molecular data and artificial intelligence in drug discovery with experience in integrative modeling of multi-modal clinical and omics data.
-
Previous experience working with large transcriptome and NGS data sets.
-
Prior consulting and/or client facing experience is highly desirable
-
Ability to work collaboratively in a team environment
-
Thrive in a fast-paced environment and willing to shift priorities seamlessly.
-
Experience with R package development.
-
Strong peer-reviewed publication record.
-
Experience with: Pandas, Num Py, Sci Py, Scikit-learn, Jupyter Notebooks, RStudio, R Package development, tidyverse, ggplot, Git, matplotlib, seaborn, HTML5, CSS3, JavaScript, D3, Plot.ly, Flask, Dask, Docker, AWS.
-
Goal orientation, self motivation, and drive to make a positive impact in healthcare.
CHI: $90,000-$135,000
NYC/SF: $100,000-$150,000
The expected salary range above is applicable if the role is performed from Illinois and may vary for other locations (California, Colorado, New York). Actual salary may vary based on qualifications and experience. Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
浏览量
0
申请点击
0
Mock Apply
0
收藏
0
相似职位

Data Scientist, Agents
Anysphere (Cursor) · SF / NY

Data Scientist
Booz Allen Hamilton · Arlington, VA

Scientist I - Inhalation Toxicologist Research Scientist
Leidos · Dayton, OH

Postdoctoral Research Scientist - Neurodegeneration
Eli Lilly · US, Indianapolis IN

Data Scientist - Applied AI Research
Fidelity · Westlake, Texas, USA
关于Tempus
Tempus
PublicTempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer.
501-1,000
员工数
Chicago
总部位置
$8.1B
企业估值
评价
10条评价
4.0
10条评价
工作生活平衡
3.8
薪酬
2.7
企业文化
3.9
职业发展
3.5
管理层
3.6
72%
推荐率
优点
Supportive management and approachable leadership
Great team culture and collaborative environment
Good benefits and health insurance
缺点
Compensation not competitive
Heavy workload and high stress during peak times
Limited career advancement opportunities
薪资范围
36个数据点
Junior/L3
Mid/L4
Senior/L5
Staff/L6
Junior/L3 · BIOINFORMATICS DATA SCIENTIST
1份报告
$156,000
年薪总额
基本工资
$120,000
股票
-
奖金
-
$156,000
$156,000
面试评价
53条评价
难度
3.5
/ 5
时长
14-28周
录用率
39%
体验
正面 64%
中性 26%
负面 10%
面试流程
1
Phone Screen
2
Technical Interview
3
System Design
4
Behavioral
5
Team Fit
常见问题
Tell me about a challenging project
System design question
Coding problem
Why this company
最新动态
Tempus Fugit - Idaho County Free Press
Idaho County Free Press
News
·
1w ago
ALB India Firms to Watch 2026 Profile: Tempus Law Associates - | Asian Legal Business
| Asian Legal Business
News
·
1w ago
Bogart Wealth LLC Raises Stock Holdings in Tempus AI, Inc. $TEM - MarketBeat
MarketBeat
News
·
1w ago
Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026 - Business Wire
Business Wire
News
·
1w ago